| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $79,246,141 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI150917 | Safety and immunogenicity of a novel Rift Valley fever candidate vaccine, RVax-1 | 000 | 4 | NIH | 2/13/2023 | $386,125 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI141661 | Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine | 000 | 5 | NIH | 10/24/2022 | $766,992 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI166985 | Novel Function(s) of Arenavirus NP Exoribonuclease | 000 | 2 | NIH | 4/20/2023 | $200,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 000 | 2 | NIH | 10/25/2022 | $400,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI143653 | Evaluating the intersection between sexually transmitted infections, inflammation and reproductive success | 001 | 5 | NIH | 3/3/2023 | $463,595 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG081900 | Comparative effectiveness of pelvic floor muscle training, Mirabegron, and Trospium among older women with urgency urinary incontinence and high fall risk: a feasibility randomized clinical study. | 000 | 1 | NIH | 5/9/2023 | $233,203 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 000 | 2 | NIH | 3/6/2023 | $118,383 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 2 | NIH | 2/16/2023 | $198,400 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK124132 | STING signaling in T cells regulation of intestinal homeostasis and inflammatorybowel diseases | 000 | 4 | NIH | 4/5/2023 | $503,932 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG081282 | Nursing homes' visitation bans during the COVID-19 pandemic: Effectiveness and consequences. | 000 | 1 | NIH | 5/31/2023 | $340,538 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM145925 | Mitochondrial translesion DNA synthesis | 000 | 1 | NIH | 4/28/2023 | $388,746 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | 90CSSG0065 | Self-Management Education Programs for Chronic Diseases in Older Population | 00 | 1 | ACL | 4/19/2023 | $599,530 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 000 | 2 | NIH | 3/6/2023 | $74,331 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 2 | NIH | 2/16/2023 | $50,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH124351 | Neurotrophin-dependent regulation of voltage-gated sodium channels | 000 | 4 | NIH | 4/25/2023 | $591,816 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI146227 | Mechanistic function of HCV NS5A targeted by the potent inhibitors | 000 | 4 | NIH | 1/23/2023 | $554,525 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01CA247595 | Bimodal Intraoral imaging device for detection of oral epithelial neoplasia | 001 | 4 | NIH | 3/16/2023 | $39,655 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG082230 | Role of microglia in cognitive resilience to AD | 000 | 1 | NIH | 4/21/2023 | $320,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K99AI168484 | Assessing the roles of viral mutations and host factors in the transmission of Mayaro virus and other alphaviruses by urban mosquitoes | 000 | 1 | NIH | 5/3/2023 | $119,264 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2RTW012239 | 2/2 - Mongolian Center for Environmental & Occupational Health - U.S. | 000 | 2 | NIH | 3/6/2023 | $100,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA053472 | Novel Addiction Neurocircuits in Cocaine Taking | 000 | 2 | NIH | 1/16/2023 | $488,840 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AT011856 | Determinants and effectiveness of non-pharmacologic pain interventions versus prescription opioids | 000 | 2 | NIH | 2/1/2023 | $36,255 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | T0839277 | Scholarships for Disadvantaged Students | 00 | 4 | HRSA | 5/26/2023 | $200,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG063945 | Phospholipase D1 Mediated Early Events Affecting Synaptic Dysfunction in Alzheimer's Disease and Related Dementia | 000 | 4 | NIH | 3/15/2023 | $395,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY031054 | Neuroprotective Role of Sirt6 in Glaucoma | 000 | 4 | NIH | 5/30/2023 | $441,997 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01CA247595 | Bimodal Intraoral imaging device for detection of oral epithelial neoplasia | 000 | 4 | NIH | 12/1/2022 | $446,140 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R00AI156012 | Viral factors responsible for Lassa virus pathogenicity | 000 | 3 | NIH | 4/21/2023 | $249,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI159702 | Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA | 000 | 2 | NIH | 11/10/2022 | $197,750 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH129354 | Prospective intergenerational mixed-methods investigation of the short- and long-term impact of COVID-19 on adolescent mental, social, and behavioral health | 000 | 1 | NIH | 11/28/2022 | $731,479 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U01AI168622 | One-Health Approach to Study Human Fasciola hepatica Transmission and Inform Strategic Control | 000 | 2 | NIH | 3/20/2023 | $480,081 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R61AG075725 | tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimer?s Disease | 001 | 1 | NIH | 4/20/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK135193 | Gut microbiota metabolite sensing licenses IEC to cross talk with T cells to inhibit intestinal inflammation | 000 | 1 | NIH | 2/8/2023 | $556,826 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA050871 | Mechanisms of prenatal opioid exposure on brain and behavior | 000 | 2 | NIH | 5/1/2023 | $631,388 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01OH012107 | Examining the Physical, Mental, and Social Health Outcomes Among Commercial Fishers to Inform Policy and Practice | 00 | 3 | CDC | 3/31/2023 | $108,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI147948 | Role of IL-17 Cytokine Networks in TB Relapse Due to HIV | 000 | 5 | NIH | 5/12/2023 | $601,802 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI176670 | Porous silicon microparticle-based subunit vaccines for SARS-CoV-2 | 000 | 1 | NIH | 2/9/2023 | $613,059 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | P01AI150585 | Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus | 000 | 3 | NIH | 3/20/2023 | $2,213,113 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U19AI142785 | Advancement of Vaccines and Treatments for Ebola and Marburg Virus Infections | 001 | 5 | NIH | 1/31/2023 | $7,043,167 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG075208 | Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality | 000 | 1 | NIH | 2/9/2023 | $318,215 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U19AI171413 | UTMB-Novartis Alliance for Pandemic Preparedness | 002 | 1 | NIH | 5/30/2023 | $18,849,015 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA052263 | AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation | 000 | 3 | NIH | 2/17/2023 | $593,890 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK124611 | Pathogenic Role of Mechanical Stress in Fibrosis and Tissue Remodeling in Crohn's Disease | 000 | 4 | NIH | 2/8/2023 | $355,500 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM130326 | Dynamics of DNA scanning and recognition by transcription factors | 000 | 5 | NIH | 1/31/2023 | $426,767 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG075208 | Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality | 001 | 1 | NIH | 3/7/2023 | $69,853 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS125778 | Role of microglia in neural infection | 000 | 2 | NIH | 12/22/2022 | $464,451 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI160226 | Preclinical development of a vaccine for Nipah virus | 000 | 3 | NIH | 2/7/2023 | $1,159,045 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R25GM134990 | PREPing for SUCCESS | 000 | 4 | NIH | 4/12/2023 | $244,865 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01HD101589 | Standardized Patient Assessment across Post-Acute Care: Opportunities and Challenges | 000 | 4 | NIH | 3/15/2023 | $126,212 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM130326 | Dynamics of DNA scanning and recognition by transcription factors | 001 | 5 | NIH | 2/17/2023 | $47,418 |
|
